Skip to the page

Data / Form D filings / DesiCorp, Inc.

DesiCorp, Inc.: Form D filings

DesiCorp, Inc., a biotechnology company in Louisville, KY, filed 5 Form D notices with the SEC between 2024 and 2026. The latest, on June 9, 2026, reports $3.5 million sold of a $6 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
201 E. JEFFERSON STREET, Louisville, KY, 40202
Phone
(502) 351-0353
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1997477

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 9, 2026Amendment$6,000,000$3,499,999$2,500,00112Mar 20, 2026sec.gov
Apr 1, 2026New notice$5,000,000$839,993$4,160,0078Mar 20, 2026sec.gov
Jan 20, 2026Amendment$8,000,000$5,188,530$2,811,47015Jul 3, 2024sec.gov
Nov 14, 2025Amendment$5,000,000$4,188,529$811,47115Jul 3, 2024sec.gov
Jul 18, 2024New notice$3,000,000$1,000,000$2,000,0005Jul 3, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Brett JanisExecutive Officer, Director
Jonathan KopecheckExecutive Officer, Director
Michael MenzeExecutive Officer, Director
Robert SaundersDirector

Every Form D from the week of Jun 8, 2026 · All recent filings in Kentucky · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what DesiCorp, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.